Creating safe and effective vaccines for flavivirus infections
A Novel Strategy for Generating Safe and Effective Flavivirus Vaccines
['FUNDING_R01'] · VIRGINIA POLYTECHNIC INST AND ST UNIV · NIH-10843236
This study is working on a new type of vaccine to help protect people from viruses like Zika and dengue, using a safe method that aims to give strong and lasting immunity, especially for those living in areas where these viruses are common.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VIRGINIA POLYTECHNIC INST AND ST UNIV (nih funded) |
| Locations | 1 site (BLACKSBURG, UNITED STATES) |
| Trial ID | NIH-10843236 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a new vaccine strategy to combat flavivirus infections, such as Zika and dengue. It aims to create a chimeric virus vaccine that combines the safety of non-replicating platforms with the strong immune response typically seen in live-attenuated vaccines. By using a unique insect-specific flavivirus, the researchers hope to generate a vaccine that can provide rapid and long-lasting immunity without the risks associated with traditional vaccine methods. Patients may benefit from this innovative approach to vaccination, especially in regions prone to outbreaks.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in or traveling to areas where flavivirus outbreaks, such as Zika or dengue, are prevalent.
Not a fit: Patients who are not at risk of flavivirus infections or those who have already been vaccinated against these viruses may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent serious flavivirus infections, improving public health outcomes.
How similar studies have performed: Other research has shown promise in developing vaccines using similar chimeric virus approaches, indicating potential for success in this novel strategy.
Where this research is happening
BLACKSBURG, UNITED STATES
- VIRGINIA POLYTECHNIC INST AND ST UNIV — BLACKSBURG, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: AUGUSTE, ALBERT J. — VIRGINIA POLYTECHNIC INST AND ST UNIV
- Study coordinator: AUGUSTE, ALBERT J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.